These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

926 related items for PubMed ID: 16023184

  • 21. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [Abstract] [Full Text] [Related]

  • 22. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M, Wright TC, Stoler MH, Ranger-Moore J, Rehm S, Aslam S, Fang Q, Volkir P, Ridder R.
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
    Hosseini MS, Khosravi D, Farzaneh F, Ebrahimi A, Arab M, Ashraf Ganjoie T, Jamdar F, Moridi A, Chehrazi M.
    Asian Pac J Cancer Prev; 2018 Nov 29; 19(11):3071-3075. PubMed ID: 30485943
    [Abstract] [Full Text] [Related]

  • 26. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears.
    Derchain SF, Rabelo-Santos SH, Sarian LO, Zeferino LC, de Oliveira Zambeli ER, do Amaral Westin MC, de Angelo Andrade LA, Syrjänen KJ.
    Gynecol Oncol; 2004 Dec 29; 95(3):618-23. PubMed ID: 15581973
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing.
    Paraskevaidis E, Malamou-Mitsi V, Koliopoulos G, Pappa L, Lolis E, Georgiou I, Agnantis NJ.
    Gynecol Oncol; 2001 Aug 29; 82(2):355-9. PubMed ID: 11531293
    [Abstract] [Full Text] [Related]

  • 29. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO, Sahai Srivastava BI, Wong C, Hempling RE, Eltabbakh GH, Piver MS.
    Eur J Gynaecol Oncol; 1998 Aug 29; 19(3):203-8. PubMed ID: 9641214
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia.
    Sarian LO, Derchain SF, Andrade LA, Tambascia J, Morais SS, Syrjänen KJ.
    Gynecol Oncol; 2004 Jul 29; 94(1):181-6. PubMed ID: 15262139
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
    Syrjänen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S.
    Anticancer Res; 2005 Jul 29; 25(5):3469-80. PubMed ID: 16101165
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
    Costa S, Sideri M, Syrjänen K, Terzano P, De Nuzzo M, De Simone P, Cristiani P, Finarelli AC, Bovicelli A, Zamparelli A, Bovicelli L.
    Acta Cytol; 2000 Jul 29; 44(3):310-8. PubMed ID: 10833984
    [Abstract] [Full Text] [Related]

  • 38. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.
    Sandri MT, Lentati P, Benini E, Dell'Orto P, Zorzino L, Carozzi FM, Maisonneuve P, Passerini R, Salvatici M, Casadio C, Boveri S, Sideri M.
    J Clin Microbiol; 2006 Jun 29; 44(6):2141-6. PubMed ID: 16757611
    [Abstract] [Full Text] [Related]

  • 39. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
    Levi AW, Kelly DP, Rosenthal DL, Ronnett BM.
    Cancer; 2003 Aug 25; 99(4):191-7. PubMed ID: 12925979
    [Abstract] [Full Text] [Related]

  • 40. Stepwise algorithm combining HPV high-risk DNA-based assays and RNA-based assay for high grade CIN in women with abnormal smears referred to colposcopy.
    Halfon P, Benmoura D, Agostini A, Khiri H, Pénaranda G, Martineau A, Blanc B.
    Cancer Biomark; 2010 Aug 25; 7(3):133-9. PubMed ID: 21263189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.